Lexicon Genetics Delivers Thirteen Novel Antigens To Abgenix For Antibody Development
05-Feb-2001 -
Lexicon Genetics Incorporated (Nasdaq: LEXG) and Abgenix, Inc. (Nasdaq: ABGX) announced today
that Lexicon has delivered to Abgenix, thirteen (13) human antigens for antibody development as part of the companies’ drug discovery alliance. This marks the first of
many antigens to be delivered to ...
antibodies
antigens
diseases
+5